within Pharmacolibrary.Drugs.ATC.C;

model C01CX09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.060000000000000005,
    adminDuration  = 600,
    adminMass      = 0.02,
    adminCount     = 1,
    Vd             = 0.000273,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Angiotensin II is a peptide hormone that causes vasoconstriction and an increase in blood pressure. It is used as a vasopressor for the treatment of hypotension, particularly in adults with septic or other distributive shock. It is approved for use in certain countries for this indication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for angiotensin II are based on published data from clinical use in adult patients with distributive shock.</p><h4>References</h4><ol><li><p>Wu, Y, &amp; Sitzmann, JV (1996). Pharmacokinetics of regional angiotensin-II: a novel biologic response modifier. <i>Annals of surgical oncology</i> 3(1) 24–28. DOI:<a href=&quot;https://doi.org/10.1007/BF02409047&quot;>10.1007/BF02409047</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8770298/&quot;>https://pubmed.ncbi.nlm.nih.gov/8770298</a></p></li><li><p>Schwocho, LR, &amp; Masonson, HN (2001). Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects. <i>Journal of clinical pharmacology</i> 41(5) 515–527. DOI:<a href=&quot;https://doi.org/10.1177/00912700122010393&quot;>10.1177/00912700122010393</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11361048/&quot;>https://pubmed.ncbi.nlm.nih.gov/11361048</a></p></li><li><p>Lo, MW, et al., &amp; Bjornsson, TD (1995). Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans. <i>Clinical pharmacology and therapeutics</i> 58(6) 641–649. DOI:<a href=&quot;https://doi.org/10.1016/0009-9236(95)90020-9&quot;>10.1016/0009-9236(95)90020-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8529329/&quot;>https://pubmed.ncbi.nlm.nih.gov/8529329</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C01CX09;
